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 The retina is well-known for its high rate of energy con-
sumption [1]. Oxygen delivery to the photoreceptors in the
outer retina differs from that in other nervous tissues, in that
oxygen is provided by diffusion from the choroidal circula-
tion, which requires very high levels of blood flow [1,2]. There
is no local coupling between metabolic expenditures of pho-
toreceptors and blood flow in the choroidal vessels, and there-
fore oxygen tension can decrease to low levels at the proxi-
mal side of the inner segment in the face of high energy ex-
penditures during dark-adaptation [2]. Furthermore, photore-
ceptor function is rapidly affected after the onset of hypoxia
[2]. The expression of the oxygen-storage molecule,
neuroglobin, in the photoreceptor inner segment further un-
derlines the importance of regulation of oxygen availability
[3]. Importantly, chronic ischemia-hypoxia of the rat retina,
induced by occlusion of both common carotid arteries, can be
associated with photoreceptor degeneration [4,5]. We have
shown in rats that such photoreceptor degeneration will occurr
with a delay of several weeks to months after occlusion of
both common carotid arteries [6]. Thus, metabolic failure and
oxidative stress may be related to slow degeneration of photo-
receptors in rodent models of ocular ischemia [5].
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Purpose: High oxygen consumption and cyclical changes related to dark-adaptation are characteristic of the outer retina.
Oxygenation changes may contribute to the selective vulnerability of the retina in retinitis pigmentosa (RP) patients,
especially for those forms involving genes with global cellular functions. Genes coding for components of the U4/U6.U5
tri small nuclear ribonucleoprotein (tri-snRNP) complex of the spliceosome stand out, because mutations in four genes
cause RP, i.e., RP9 (PAP1), RP11 (PRPF31), RP13 (PRPF8), and RP18 (PRPF3), while there is no degeneration outside
the retina despite global expression of these genes. With the assumption that variable oxygenation plays a role in RP forms
related to pre-mRNA splicing and the retina and brain are similar, we searched a data collection of ischemia-hypoxia
regulated genes of the brain for oxygen regulated genes of the U4/U6.U5 tri-snRNP complex.
Methods: A database of ischemia-hypoxia response (IHR) genes in the brain was generated from gene expression profil-
ing studies [n=24]. Public databases (NCBI) were searched for RP genes with global function that are expressed in the
brain. From the IHR gene list, we extracted genes that were directly related to retinal degeneration through a listed
mutation (OMIM, Retnet, RISN). The database was then examined for indirect links to RP forms affecting the U4/U6.U5
tri-snRNP complex by searching for IHR genes contributing to this complex. Potential expression of matched genes in the
retina was ascertained using NEIBank. Immunohistochemistry was used to localize a selected protein of the U4/U6.U5
tri-snRNP complex in cynomolgus monkey and human retina specimens.
Results: The approach identified genes that cause retinal degeneration (CNGB1, SEMA4A, RRG4) or developmental
changes (SOX2) when mutated. One IHR gene, Pim1, is the immediate binding partner for PAP1 (RP9). Three IHR genes
linked the U4/U6.U5 tri-snRNP complex to regulation by oxygenation: PRPF4; SART1, also known as 110 kDa SR-
related protein of the U4/U6.U5 tri-snRNP or as hypoxia associated factor (HAF); and LSM8, U6 snRNA-associated Sm-
like protein. The 110 kDa SR-related protein was localized in all retinal cells including photoreceptors.
Conclusions: Regulation by changes in oxygenation within the U4/U6.U5 tri-snRP complex could be particularly impor-
tant for photoreceptors where oxygen consumption follows a circadian rhythm. If the U4/U6.U5 tri-snRP complex is
already impaired by mutations in any of the four genes causing RP, it may be unable to follow properly the physiological
demands of oxygenation which are mediated by the four hypoxia-regulated proteins emerging in this study. Selective
vulnerability may involve complex combinations of widely expressed genes, specific cellular functions and local energy
availability.
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125Several studies have suggested that the high rate of oxy-
gen consumption of photoreceptors is involved in the vulner-
ability to retinitis pigmentosa (RP) [1,7-11]. Such interaction
could be quite general, in that moderately dysfunctional pho-
toreceptors carrying RP mutations in a variety of cell-specific
genes could be prone to undergo apoptosis when challenged
with transient energetic deficits, e.g. due to changes in mem-
brane function and calcium homeostasis [11]. The link could
also be more specific through regulation of gene expression
in response to the state of oxygenation. For example, the RP1
gene was identified as oxygen-regulated photoreceptor pro-
tein 1 (ORP1) when retinal gene expression was studied un-
der conditions of hypoxia [12]. Bernstein et al noted that the
expression of a given disease causing gene within the retina
may not be selective for the cells affected by degeneration
[13]. Furthermore, mutations in ten genes cause retina-spe-
cific degeneration although these genes are also expressed in
several other organs, i.e. the RP9 gene PAP1, IMPDH, MERTK,
RPGR, RP2, CHM, TIMP3, and three pre-mRNA splicing fac-
tors [14]. Retina-specific splice variants and high expression
of the gene in the retina relative to other organs may explain
the selective vulnerability in the case of IMPDH1 mutations
in RP10 [15,16]. Selective expression of a critical binding
partner in the retina is another possible scenario [16]. In this
paper, we postulate that widely expressed genes causing RP
may be components of protein complexes whose function is
dependent on oxygenation through regulation of gene expres-
sion and that the cyclical character of oxygenation in the outer
retina introduces a selective deleterious effect on photorecep-
tors. Thereby, we will primarily use the term “hypoxia” to
indicate a critically low level of oxygenation, whereas abnor-
mally high levels of oxygen and oxidative stress may as well
be involved [10].
Selective degeneration of photoreceptor cells is found in
autosomal dominant retinitis pigmentosa (ADRP) associated
with mutations in genes coding for proteins involved in pre-
mRNA splicing in the spliceosome. This selectivity for the
retina is striking, because the genes involved are house keep-
ing genes [14,16]. RP11 (OMIM 600138) is associated with
mutations in precursor mRNA-processing factor 31 (PRPF31)
[17-19]; RP13 (OMIM 600059) with precursor mRNA-pro-
cessing factor 8 (PRPF8) mutations [20]; and RP18 (OMIM
601414) with precursor mRNA-processing factor 3 (PRPF3)
mutations [21]. PRPF31 and PRPF3 are protein components
of the U4/U6 small nuclear ribonucleoprotein (snRNP) com-
plex, and PRPF8 is the core component of the U5 snRNP
[14,16]. Additionally, although the evidence is not as strong,
mutations in Pim1 kinase associated protein (PAP1) were found
to cause RP9 (OMIM 607331) [22]. PAP1 has also been char-
acterized as a component of the U4/U6.U5 tri-snRNP com-
plex, which interacts with PRPF3 [23,24]. These four proteins
(PRPF31, PRPF8, PRPF3, PAP1) contribute to the formation
and function of the U4/U6.U5 tri-snRNP complex, which in-
volves at least thirty proteins [14,16]. Although pre-mRNA
splicing should be important for all cells in the body, only
photoreceptor cell death occurs in these four forms of ADRP.
There is no evidence in the literature that retina-specific splice
variants exist for these genes. Haploinsufficiency has been
proposed as the pathogenic factor in ADRP [16,18], especially
for PRPF31 (RP11) [17,25-27]. One scenario for the selec-
tive vulnerability of photoreceptors is quantitative, the regu-
lation of splicing is necessary for photoreceptors because the
levels of mRNA for rhodopsin (and perhaps other genes) un-
dergo considerable change due to the circadian rhythm
[18,21,26]. Recently, photoreceptor genes affected by PRPF31
mutations have been reported [28]. Other studies have shown
changes in nuclear trafficking caused by a reduced solubility
of mutant PRPF31 [29]. Mutant PRPF3 associated with RP
differed from the wild type protein by forming abnormally
big protein aggregates in transfected photoreceptor cells, and
aggregation of mutant PRPF3 inside the nucleus triggered
apoptosis in photoreceptor cells [30]. Yeast two-hybrid analy-
ses have suggested a link between RP and an aberrant hPrp31-
hPrp6 interaction that blocks U4/U6-U5 tri-snRNP formation
[31]. In the present study, we examined the hypothesis that
the function of the U4/U6.U5 tri-snRNP complex is oxygen
regulated because of the energy dependence of splicing [32],
and that this mechanism provides specificity for the effects of
the mutation on the outer retina.
Using a theoretical approach, we have previously explored
links between the genetics of nervous system disorders and
oxygen regulation of gene expression [33]. We compiled a
listing of genes regulated by ischemia-hypoxia in the rodent
brain from a detailed evaluation of microarray studies and the
original literature, and correlated this list with a set of candi-
date genes for schizophrenia [33]. At present, the information
for gene expression changes in ischemia-hypoxia in the retina
[34] is too limited to perform a similar analysis for genetic
disorders of the retina. It has been proposed that gene expres-
sion related to fundamental pathological events in the brain
and retina should be sufficiently similar, so that data collec-
tions can be carried over from the brain to the retina in a theo-
retical approach [35]. Such strategy could be especially fruit-
ful for globally expressed RP genes as discussed in the pre-
ceding text. In this paper, we used the brain-based database
and literature searches to look for potential connections be-
tween globally expressed RP genes and changes in oxygen-
ation with a specific focus on pre-mRNA splicing. We identi-
fied four genes involved in the U4/U6.U5 tri-snRNP of the
spliceosome during this search. Databases for retinal gene
expression were then used to confirm the expression of these
genes. Finally, immunohistochemistry was used to identify the
protein expressed by one of the four genes in the monkey and
human retina.
METHODS
Stage A:  We built a database of 24 published gene expression
studies in brain ischemia-hypoxia, starting with our cDNA
microarray study of focal brain ischemia [36]. Gene lists were
transformed into an Excel (Microsoft) datasheet, and genes
were identified by running clone identification numbers for
individual probes through Nucleotide, UniGene, and Entrez
Gene (NCBI). Selected probes of the microarray analysis were
verified by using BLAST searches (Nucleotide, NCBI). We
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126generated an ischemia-hypoxia response (IHR) gene list after
sorting by gene symbol and removing redundancy. Informa-
tion for individual genes was retrieved from OMIM (NCBI)
and the literature (PubMed, NCBI). Genes were collected un-
der different categories that were defined by mechanisms of
ischemic-hypoxic cell damage and neurodegeneration. Two
studies relevant to hypoxia regulation in neurons by hypoxia
inducible factor 1 and 2 (HIF-1, HIF-2) were considered in
addition [37,38]. Information for gene expression studies in
retinal ischemia was searched using PubMed, but only one
dataset [34] was found to be in parallel with the IHR gene list.
We also reprobed the original dataset of our microarray study
[36] for specific genes encountered during the search.
Stage B:  UniGene and PubMed searches were used to
test whether widely expressed RP genes were also found in
the brain. A listing of RP genes with widespread expression
and function were taken from the review of Pacione et al. [14]:
RP9/PAP1, IMPDH1, MERTK, RPGR, RP2, CHM, TIMP3,
and three pre-mRNA splicing factors. An update was per-
formed, using database searches the Retinal Information Net-
work (RetNet) and the Retina International Scientific News-
letter (RISN), which led to the addition of SEMA4A [39] and
CA4 [40]. The analysis of brain expression aimed at globally
expressed genes involved in RP and was not designed as a
comprehensive study of brain expression of all RP genes.
Stage C:  The IHR gene list was then searched for genes
involved in RP and related retinal dystrophies. Gene symbols
were run through OMIM to see whether a role in specific oph-
thalmic diseases was listed or if the gene was under consider-
ation as a risk gene. Lists in RetNet and RISN were regularly
surveyed for matches to ischemia-hypoxia regulated genes.
Several retina-specific disease genes were found oxygen regu-
lated, and one RP-interacting gene involved in pre-mRNA
splicing (RP9 see Results) was retrieved.
Stage D:  We then focused on genes related to pre-mRNA
splicing in the IHR gene list, because of the unique
overpresentation of genes of the U4/U6.U5 tri-snRNP com-
plex among widely expressed RP genes [14], the expression
of these genes in the brain as documented at Stage B, and the
finding of one gene related to pre-mRNA splicing and RP at
Stage C (see Results). IHR genes related to mRNA process-
ing were identified, and specific links to the U4/U6.U5 tri-
snRNP were explored using information available through
Entrez Gene, OMIM, and PubMed. The purpose of this analy-
sis was to identify relations between the hypoxia regulation
and pre-mRNA splicing, i.e. oxygen dependence of genes in-
teracting with the RP genes in the spliceosome.
Stage E:  To analyze the expression of genes identified
during Stage D in the human retina, a database search for
mRNA in NEIBank at the National Eye Institute was carried
out. Gene expression profiles in the mouse retina were exam-
ined using serial analysis of gene expression (SAGE) derived
databases [41]. The EyeBrowse (Browse) database was also
used. This database provides an alignment of eye specific ESTs
with the human genome sequence according to the Genome
Browser (UCSC). Studies with immunohistochemistry for a
selected protein are described in Stage H.
Stage F:  Bioinformatics were used to identify target genes
regulated by HAF (i.e. SART1), which is one of the oxygen-
ation-regulated members of the U4/U6.U5 tri-snRNP complex
(see Results). The EP17 consensus sequence (5'-CCC CCA
CCC CCA CCC GC-3') for HAF binding in the promoter of
the EPO gene [42] was used in a BLAST (NCBI) search for
“short nearly exact matches”. Only fully annotated genes and
hits on putative regulatory regions were evaluated. Published
information was retrieved to connect such genes to retinal func-
tion and pathology.
Stage G:  This study was conducted after approval of a
protocol by the Animal Care and Use Committee and Review
Board for Animal Research of the University of Miami and
conformed to the Statement for the Use of Animals in Oph-
thalmic and Vision Research by the Association for Research
in Vision and Ophthalmology (ARVO). Whole eye globes were
provided in accordance with a university-wide ACUC ap-
proved Tissue Sharing Protocol. Whole eyes of two year old,
healthy, male cynomolgus monkeys (Macaca fascicularis)
were received immediately after euthanasia and the posterior
pole was dissected less than 2 h postmortem, immediately fixed
by immersion in 10% buffered formalin for 16 h, and then
transferred to phosphate buffered saline (PBS). The retinas of
n=3 monkeys were processed the immunohistochemical study
(supplementing stage E of the analysis). The tissue were em-
bedded in paraffin, and sections were cut with a microtome to
8 µm thickness, then mounted on glass slides coated with poly-
L-lysine (Sigma-Aldrich, St. Louis, MO). Immunohistochem-
istry was performed employing the avidin-biotin (ABC) tech-
nique using antigen retrieval with microwave treatment [6].
Sections were rinsed with PBS, then incubated in 0.3% H2O2
for 15 min to inactivate endogenous peroxidase and then
blocked with 10% normal goat serum, 0.25% Triton X-100,
and Avidin D solution (Avidin/Biotin blocking kit, Vector,
Burlingame, CA) for 30 min. Next sections were washed with
0.25% Triton X-100 in PBS and incubated in PBS containing
0.25% of Triton X-100, biotin solution (avidin/biotin block-
ing kit, Vector), 1% normal goat serum, and the primary anti-
body for 1 h at room temperature. Affinity-purified rabbit an-
tibodies to an N-terminal sequence of the 110 kDa SR-related
protein of the U4/U6.U5 tri-snRNP were kindly provided by
Drs. Olga V. Makarova and Evgeny M. Makarov, and Prof. R.
Luehrmann, Department of Cellular Biochemistry, Max-
Planck-Institute for Biophysical Chemistry, Goettingen, Ger-
many [43]. Antibodies were applied at a dilution of 1:200.
Sections were washed with 0.25% Triton X-100 in PBS and
treated with biotin-conjugated goat anti-rabbit IgG (1:250; BA-
1000; Vector) followed by streptavidin-HRP (K0377; Dako,
Carpintera, CA). Diaminobenzidine (0.05%) including 0.003%
H2O2 was used for the permanent localization of peroxidase
activity. Omission of the primary antibody and absorption with
the native immunogenic peptide served as control. Sections
were dehydrated in a series of alcohols and xylene, and
coverslipped with DePeX (Aldrich, Milwaukee, WI). Some
sections were counterstained with hematoxylin to visualize
the nucleus.
Retinal specimens from a 46 year old female donor be-
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127came available (University of Regensburg, Germany) within
1 h after enucleation due to severe herpes simplex keratitis.
The tissue was fixed in 4% paraformaldehyde in PBS (pH
7.4) overnight at 4 °C. Specimens were embedded in paraffin,
and sections were cut at 2 µm with a microtome, then fixed on
Superfrost® plus glass slides (Menzel, Braunschweig, Ger-
many). Immunohistochemistry was performed with a modi-
fied ABC technique, using antigen retrieval with microwave
treatment. Sections were incubated in citric acid/citrate buffer
(0.2 mM citric acid, 9.8 mM sodium citrate, pH 7.3) for 2 min
at 800 W and then 10 min at 240 W in a microwave oven. The
rabbit antibody to an N-terminal sequence of the 110 kDa SR-
related protein of the U4/U6.U5 tri-snRNP was applied in a
1:200 dilution and incubated using Shandon Coverplates
(Thermo, Pittsburgh, PA) and the DakoCytomation LSAB2
System-HRP (K0672, DakoCytomation, Carpinteria, CA) ac-
cording to the manufacturers’ instructions. Primary antibody
absorbed with the native peptide served as control. Sections
were dehydrated and coverslipped with Entellan new (Merck,
Darmstadt, Germany).
Stage H:  Based on the matches found for pre-mRNA
splicing (see Results), it was considered whether other RP
forms may involve genes related to pre-mRNA splicing. Genes
identified at Stage D were analyzed. Human, mice and dog
gene loci were retrieved from the Genome Browser and
OMIM. Chromosomal localizations were checked in the RISN
for related retinal dystrophies and for RP forms in which the
underlying gene has not yet been identified. The literature
[44,45] and the RISN animal database were searched for mice
and dog retinal disorders.
Stage I:  Several studies have stressed the importance of
oxidative stress for photoreceptors in RP [5,10]. The IHR da-
tabase was built upon experiments using recirculation and
reoxygenation of the brain after ischemia, which leads to oxi-
dative stress. If genes related to oxidative stress are an intrin-
sic part of the database, correlations with retinal genes may
arise from oxidative stress. To estimate this contribution, an
additional database specific for the genomic response to oxi-
dative stress was generated based on the transcription factor
nuclear factor erythroid-derived 2-like 2 (NRF2) [46]. NRF2
mediates the response to oxidative stress by binding to the
antioxidant response element (ARE). Wang et al recently pro-
vided databases of NRF2-target genes [46]. The NRF2-ARE
related databases were then scanned for retinal disorders (as
in Stage C) and for genes related to pre-mRNA splicing (as in
Stage D).
RESULTS
Stage A: Database of ischemia-hypoxia response genes
of the brain:  About 2,500 gene entries were collected from
24 microarray studies of ischemia-hypoxia in the brain. Using
the clone ID number, we found about 1,750 genes could be
linked to a gene symbol, forming the IHR gene list. Of these,
78% genes were only found once and 22% were found two or
more times. The IHR genes made up 7% of all genes. The
genes listed in a study of retinal ischemia [34] overlapped by
about 40% with the genes in the IHR gene list obtained in the
brain. This comparison provides proof of principle that many
genes studied in the brain are likely to be involved in the retina
under conditions of abnormal oxygenation [35].
Stage B: Brain expression of ubiquitously expressed re-
tinitis pigmentosa genes:
The expression profile of the RP genes with global ex-
pression listed in the review of Pacione et al. [14] and of two
additional genes (CA4 [39], SEMA4A [40]) was examined by
using transcriptome information from UniGene. Expression
in the brain was listed for RP9/PAP1, IMPDH1, MERTK,
RPGR, RP2, CHM, TIMP3, PRPF3, PRPF8, PRPF31,
SEMA4A and CA4. Thus, a database established in the brain is
suitable to explore features of regulation for these RP genes.
Stage C: Ischemia-hypoxia response genes related to re-
tinitis pigmentosa and other retinal dystrophies:
When probing the IHR gene list, several genes related to
RP and retinal dystrophies presented as ischemia-hypoxia regu-
lated. CNGB1 is mutated in autosomal recessive retinitis
pigmentosa (ARRP, OMIM 600724) and is expressed in the
brain (UniGene Hs.147062), where it was found regulated in
ischemia [47]. Mutations of SEMA4A were found in RP35
(OMIM 610282) and in dominant cone-rod dystrophy (CRD;
listed in RISN) [39], SEMA4A is ischemia regulated in the
brain [48]. RRG4 mRNA (UNC119 - HRG4) was found down-
regulated after neonatal brain ischemia/hypoxia [49], and
mutations in this gene cause a rare form of cone-rod dystro-
phy - CRD (OMIM 604011) [50]. SOX2 mutations cause
anophthalmia (OMIM 184429) and brain malformations
[51,52]. Sox2 is down-regulated in brain ischemia [48].
Stage D: Ischemia-hypoxia response genes in the U4/
U6.U5 tri-snRNP complex:  Our analysis focused on genes
involved in pre-mRNA splicing due to the unique situation
that four RP genes with global expression contribute to one
functional protein complex. Hypoxia regulation of genes in-
teracting with RP genes within the same protein complex may
exert an indirect effect of oxygenation. There were 37 genes
related to mRNA processing on the IHR gene list and in pub-
lications on HIF targets in neurons [37,38]. When gene prod-
ucts were examined for a specific role in the U4/U6.U5 tri-
snRNP complex, four genes were identified. A complete ex-
pression listing of genes from brain involved in mRNA pro-
cessing or under hypoxia regulation is still not not available.
Therefore, an enrichment of hypoxia controlled genes among
the mRNA processing genes cannot be accurately determined.
The following estimate can be made. Based on data by Pacione
et al. [14], 30 genes out of all genes (ca. 28,000) code for the
protein components of the U4/U6.U5 tri-snRNP complex.
Thus, among the n=1,750 genes of IHR gene database, two
genes could be related to the U4/U6.U5 tri-snRNP complex
by chance, whereas four genes were observed.
The first gene was precursor mRNA-processing factor 4
(PRPF4) which was found upregulated in global brain ischemia
[53]. The presence of PRPF4 in U4/U6.U5 tri-snRNPs has
been described whereby PRPF4 was tightly associated with
U4/U6 snRNP [54,55]. PRPF4 binds to the central region of
PRPF3 (causing RP18), and PRPF3 may recruit PRPF4 for
the U4/U6 snRNP assembly [56].
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128The second gene found was SART1, human squamous cell
carcinoma antigen recognized by T cells 1 [57]. This gene
was reported to be down-regulated in a rat model of neonatal
ischemia/hypoxia of the brain [49]. Human SART1 (GeneID
9092; OMIM 605941) has been also characterized as the 110
kDa SR-related protein of the U4/U6.U5 tri-snRNP [43], which
is critically important for the recruitment of the U4/U6.U5 tri-
snRNP complex to the pre-spliceosome [43]. Additional in-
formation for SART1 and a role in hypoxia was found. The
original dataset of our cDNA microarray study in brain is-
chemia [36] showed a trend for down-regulation of the mouse
Sart1 mRNA (-1.5) that was measured with the probe sequence
AA607769 (Nucleotide, NCBI). A BLAST search of the probe
sequence (AA607769) showed 97% identity with clone
AF129931.1 which was listed as “mus musculus hypoxia as-
sociated factor (Haf)” while being linked to Sart1 in GeneID
20227 (Entrez Gene, NCBI). By following the term “hypoxia
associated factor (Haf)” in the original literature, we found
HAF was originally characterized during the analysis of the
hypoxia induced expression of EPO and vascular endothelial
growth factor (VEGF) under hypoxic conditions [42,58].
The third gene was LSM8, U6 snRNA-associated Sm-like
protein, which was down-regulated in focal ischemia in mice
[48]. Achsel et al. [59] showed that the so-called LSm pro-
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Figure 1. Immunostaining for 110 kDa SR-related protein in cynomolgus monkey retina.  Immunohistochemical detection of the 110 kDa SR-
related protein of the U4/U6.U5 tri-snRNP (hypoxia-associated factor) in paraffin sections of the cynomolgus monkey retina. A: View of the
central retina; B: view of the peripheral retina. Note that the dark signal in the retinal pigment epithelium (RPE) and choroid derives from the
melanin. These areas were included in the image to illustrate the total absence of specific immunolabeling from the outer segments. The
following abbreviations were used in this figure: ganglion cell layer (GCL); inner nuclear layer (INL); inner plexiform layer (IPL); inner
segments of photoreceptors (IS); outer nuclear layer (ONL); outer segments of photoreceptors (OS); retinal pigment epithelium (RPE). The
calibration bar is equal to 40 µm.
129teins (which are related to the “Sm” proteins binding to the
Sm site of small nuclear RNAs) facilitate the formation of
U4/U6 duplexes.
The fourth gene was Pim1, which was found to be strongly
upregulated in an extended analysis of our microarray study
[36]. Pim1 binds to PAP1 [60], the gene carrying mutations in
RP9 [22], which, in turn, contributes to the U4/U6.U5 tri-
snRNP complex [23,24].
Stage E: Expression information for selected genes:
Homo sapiens PRPF4 mRNA was found in the NEI “human
retina non-normalized” database (NbLib0042); and clone
XM_131444 was linked to Prpf4 in the “dbEST mouse retina
(non-normalized) data collection” (NbLib0027). Expression
of SART1 (clone AF353625) was detected in the dbEST hu-
man retina list. Gene expression profiling using SAGE pro-
vided evidence for Sart1 mRNA expression in the mouse retina
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Figure 2. Immunostaining for 110 kDa SR-related protein in human retina.  Immunohistochemical detection of the 110 kDa SR-related protein
of the U4/U6.U5 tri-snRNP (hypoxia-associated factor) was carried out in paraffin sections of the peripheral human retina. The dark signal in
the retinal pigment epithelium (RPE) and choroid derives from the melanin. These areas were included in the image to illustrate the total
absence of specific immunolabeling from the outer segments. A: Distinct cellular labeling was obtained with the antibody to 110 kDa SR-
related protein of the U4/U6.U5 tri-snRNP. B: Immunoreactivity was absent after absorption of the primary antibody with immunogenic
peptides. The following abbreviations were used in this figure: ganglion cell layer (GCL), inner nuclear layer (INL), inner plexiform layer
(IPL), outer plexiform layer (OPL), inner segments of photoreceptors (IS), outer nuclear layer (ONL), and outer segments of photoreceptors
(OS). The calibration bar is equal to 40 µm.
130and in the microdissected outer nuclear layer [41]. Expression
of LSM8 mRNA was listed for the eye in UniGene (Hs.446179)
but not in NEIBank. A subsequent search in EyeBrowse
showed an alignment of eye ESTs to the human genome se-
quence for PRPF4 (retina, BQ638822), SART1 (retina,
W27222; RPE, BM694274), and PIM1 (RPE, CA390708).
Stage F: Putative target genes for SART1/HAF:  HAF
regulation has been shown for EPO and VEGF [42,58]. These
genes are involved in retinal pathology. Therefore, additional
genes regulated by HAF could be relevant to retinal function
and pathology. Targets of SART1/HAF regulation were trapped
using the EP17 consensus sequence for HAF binding in the
promoter of the EPO gene [42] in a BLAST search for “short
nearly exact matches”. Ten annotated genes had matches in
putative regulatory regions (i.e. outside protein coding se-
quences). Two of these putative HAF target genes were of
interest for retinal degenerations: (a) Mm. ATPase, Na+/K+
transporting, beta 2 polypeptide (Atp1b2) was known origi-
nally as AMOG-glial cell adhesion molecule (16/17 matches,
NM_031415, 3' UTR), and disruption of Amog in mice leads
to apoptotic cell death of photoreceptors [61]; and (b) Neuro-
blastoma, suppression of tumorigenicity (Nbl1, “DAN”; 16/
17 matches, NM_008675, 3' UTR) is known to be regulated
by brain ischemia and is expressed in the eye.
Stage G: Immunohistochemical study:  Immunoreactiv-
ity for the 110 kDa SR-related protein was found in all retinal
cells of the cynomolgus monkey (Figure 1). Strong labeling
with a fine granular pattern was obtained in the nucleus of
retinal ganglion cells (RGCs). The cytoplasm of large RGCs
also showed immunoreactivity. Nuclei of neurons of the inner
nuclear layer were positive. Strong expression was found in
the nuclei of photoreceptors and in the inner segments, whereas
the outer segments were negative. Nuclei of the retinal pig-
ment epithelium (RPE), vascular cells, and optic nerve glial
cells were also labeled. Specific labeling was absent after
omission of the primary antibody and after absorption of the
primary antibody with the native peptide. Subsequently, sec-
tions of a human retina were labeled, using the ABC tech-
nique for detection (Figure 2). The staining pattern obtained
in the human retina was identical to that seen for the monkey
retina. Staining of the nucleus was seen for RGCs and cells in
the inner nuclear layer. The nuclei and the inner segments of
photoreceptors showed immunoreactivity whereas the outer
segments were unlabeled. The RPE and choroidal vessels could
not be evaluated due to the presence of pigment. All
immunostaining was absent in absorption controls. A fine band
of labeling was seen in the OPL of the primate and human
retinas (Figure 1 and Figure 2), which remains unexplained,
because generalized staining indicative of expression in syn-
apses or other small organelles was not found. This raises the
question whether splicing proteins can be localized to the spe-
cialized dendrites of the axonless horizontal cells in OPL.
Stage H: Links between splicing and additional forms of
retinitis pigmentosa:  Several RP genes remain to be identi-
fied. The loci for the hypoxia-regulated genes related to the
U4/U6.U5 tri-snRNP complex by our analysis (PRPF4, SART/
HAF1, LSM8, PIM1) were scanned in OMIM and RetNet.
SART1/HAF is on 11q13, where a locus for the autosomal
dominant neovascular inflammatory vitreoretinopathy (VRNI)
was mapped (OMIM 193235). VRNI is a blinding disorder
that presents with some clinical features of RP. The mouse or
dog orthologs did not map to loci containing novel retinal dis-
orders.
Stage I: Exploring a role for gene regulation by oxidative
stress:  Since several studies have stressed the importance of
oxidative stress for photoreceptors in RP [5,10], the databases
provided by Wang et al. [46] for the genomic response to oxi-
dative stress were examined. Combining the data provided by
Wang et. (supplemental tables 2 and 3 in Wang et. paper) [46];
n=674 putative putative NRF2- target genes were available
for analysis which were scanned for genes related to retinal
disorders. Matches were found for CACNA1F (Night Blind-
ness, congenital, stationary, X-linked, Type 2- CSNB2; OMIM
300071), GNAT1 (Night Blindness, congenital, stationary,
autosomal dominant 3-CSNBAD3; OMIM 610444), RHO
(Retinitis pigmentosa 4-RP4; OMIM 180380; also, Night
Blindness, congenital, stationary, autosomal dominant 1-
CSNBAD1; OMIM 610445), and OAT (Gyrate atrophy;
OMIM 258870). We reencountered PIM1 and SEMA4A, sug-
gesting a role of oxidative stress for the regulation of these
two matched IHR genes. When looking for additional genes
related to the U4/U6.U5-tri-SNP, no genes were found in the
list of fully annotated NRF2 target genes (n=412) that were
provided by Wang et al. (supplemetal table 2 in Wang et. pa-
per) [46]. This negative finding indirectly suggests that the
correlations found at stage D are due to a hypoxic component
which is in line with the original hypothesis.
DISCUSSION
 Cyclical changes between light and dark are associated with
considerable physiological changes in oxygen levels at the
level of the outer retina [1,2]. Therefore, excessive metabolic
stress in photoreceptors could be expected to create specific
localized problems resulting in RP forms that involve widely
expressed genes, e.g. genes involved in dysfunction of pre-
mRNA splicing. To estimate which genes could be regulated
by variable oxygenation in the retina, we applied a compara-
tive analysis of gene expression under experimental ischemic-
hypoxic conditions in the brain, based on the hypothesis that
similar genes are regulated in the brain and retina. The hy-
pothesis was supported by the similarity between changes seen
in the brain and the retina after ischemia [6] and by the evalu-
ation of gene expression profiles in one study on the ischemic
retina [34]. Several genes related to RNA processing turned
out to be regulated after ischemia-hypoxia in the brain, and,
four genes could be specifically related to the U4/U6.U5 tri-
snRNP. Database searches showed that these genes were also
likely to be expressed in the retina.
The first gene found was PRPF4. The PRPF4 protein
binds to the central region of PRPF3. Because mutations in
PRPF3 cause RP18 [21] and PRPF3 interacts with PAP1 (caus-
ing RP9), a strong hypothetical link to ischemia-hypoxia (oxy-
genation) involvement in ADRP emerged from the present
analysis. The second IHR gene was the 110 kDa SR-related
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HAF [42,43,57]. Immunohistochemistry verified expression
in photoreceptors of the primate and human retina. Dual func-
tions of proteins in transcriptional regulation and pre-mRNA
splicing have been recognized [62]. Accordingly, the 110 kDa
SR-related protein is essential for the recruitment of the U4/
U6.U5 tri-snRNP complex to the spliceosome [43], and the
same protein plays a role in the regulation of expression of
EPO and VEGF by hypoxia under the name of HAF [42,58].
Intriguingly, EPO showed protective functions for photore-
ceptors [63]. In the photoreceptor layer, intrinsic physiologi-
cal changes in oxygenation [2] could control the activity of
the SART1/HAF which in turn affects the expression as well
as the splicing of specific target genes, e.g. EPO, VEGF,
Atp1b2, and Nbl1. The LSM8 gene can be also set in the con-
text of the U6 complex [59]. The fourth gene found regulated
in the brain, PIM1, targets PAP1 (causing RP9) for phospho-
rylation in vitro [60]. A 2004 study showed that the interac-
tion between PAP1 and PIM1 does not play a major role in
vivo [23], so it remains to be seen whether PAP1 is indirectly
regulated by oxygenation.
Regulation of PRPF4, SART1/HAF, LSM8, and PIM1 by
changes in oxygenation argues for a reversible functional
change within the U4/U6.U5 tri-snRP complex, which could
be especially important for photoreceptors where oxygenation
and oxygen consumption follow a circadian rhythm. Muta-
tions in any of the four ADRP genes involved in the assembly
of the U4/U6.U5 tri-snRP complex, i.e. PRPF31 (RP11),
PRPF8 (RP13), PRPF3 (RP18), and PAP1 (RP9), may influ-
ence either the ability to undergo this change or its reversibility.
If the U4/U6.U5 tri-snRP complex is already impaired by
mutations in any of the four genes causing ADRP, it may be
unable to deal with the physiological changes of oxygenation
which are mediated by the four hypoxia-regulated proteins
emerging in this study. A dominant negative effect is not sup-
ported by this mechanism as well not by the late onset of ADRP
in the patients. Therefore, a reduced function of the U4/U6.U5
tri-snRP complex under hypoxic conditions will cause an al-
ternating haploinsufficiency during the diurnal rhythm, which
exerts a slow, persisting damage to the photoreceptor cells,
resulting in late onset disease. However, it should be noted
that the correlations found here cannot be taken to indicate an
exclusive importance of hypoxia for the U4/U6.U5 tri-snRNP
as compared to other protein complexes. Analysis of other
components of the spliceosome may be fruitful.
Oxidative stress has been considered to be a major factor
in retinal degeneration [5,10]. Our analysis has stressed “hy-
poxia” throughout, but it should be noted that hypoxia and
oxidative stress are closely associated. It has been argued that
photoreceptors are optimally stable in hypoxia, and are desta-
bilized by both hypoxia and hyperoxia [64].
In fact, the IHR gene database contains multiple genes
from the brain subjected to reoxygenation when profound oxi-
dative stress occurs [36]. We surveyed databases from a re-
cent bioinformatics study [46] to probe for a specific contri-
bution of antioxidant genes, whose function is to counteract
oxidative stress. PIM1 was the only gene with a role in pre-
mRNA splicing found to match. This comparison renders it
more likely that hypoxia and metabolic stress were involved.
There is an oxygen sink on the promixal side on the inner
segment and outer nuclear layer where the gene products of
the ADRPs related to pre-mRNA splicing should play impor-
tant roles [2]. Furthermore, the initial loss of photoreceptors
in RP may lead to an alleviation of the physiological hypoxia
and relative hyperoxia [65].
More than 40% of cases of ADRP could not be linked to
known mutations [66], and novel genes may also relate to pre-
mRNA splicing. For the RP33 locus, ASCC3L1, also known
as U5 snRNP-specific protein, was already suggested as a can-
didate gene [67].
Interestingly, known RP genes may play a larger role in
the nucleus than is presently recognized. The (recessive) RP26
gene encodes ceramide kinase-like protein (CERKL) which
was linked to nuclear functions. As noted by Inagaki et al.
[68] proteins encoded by (dominant or recessive) RP1 and
(recessive) RP14 are known to be localized to the nucleolus
[68]. Yoon and colleagues showed that the RP2 gene product
undergoes re-localization into the nucleus upon treatment of
cells with DNA damaging agents inducing oxidative stress,
most notably solar simulated light and UVA radiation, and
proposed a previously unrecognized role as a DNA damage
response factor and 3' to 5' exonuclease [69]. Inosine mono-
phosphate dehydrogenase type I (IMPDH1) mutations in RP10
(OMIM 146690) may influence the binding of the protein to
single stranded nucleic acids [70].
The concept of an influence of oxygenation on gene ex-
pression and function of a protein machinery is only one of
several explanations for selective vulnerability of photorecep-
tors in RP forms that involve widely expressed RP genes. Other
possible explanations include strong differences in expression
across different organs or even the presence of retina-specific
splice variants [16]. Nevertheless, changes in gene expression
and function due to strong local changes in oxygenation may
relate to the clinically variable and delayed manifestation of
ADRP. Hypoxia has already been implicated in the variable
clinical manifestation of RP1 [14,71]. Two of the ADRP forms
related to pre-mRNA splicing show variable clinical expres-
sion, which could hint at a gene-environment interaction. Large
variations in retinal dysfunction across family members with
RP9 have been reported [14,72], and RP11 caused by PRPF31
mutations shows generation skipping [26,27,66]. It will be
important to examine the critical threshold concentrations for
the respective proteins. Based on the findings in this paper,
we feel there is a need for further studies of genes related to
the U4/U6.U5 tri-snRNP, using retinal tissue under ischemic-
hypoxic conditions.
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